SUPRIYA LIFESCIENCE
Back to Cashflow Statement
|
SUPRIYA LIFESCIENCE Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-22 Cr | ₹-10 Cr | ₹150 Cr | ₹-15 Cr | ₹-29 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUPRIYA LIFESCIENCE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-22 Cr |
Mar2023 | ₹-10 Cr |
Mar2022 | ₹150 Cr |
Mar2021 | ₹-15 Cr |
Mar2020 | ₹-29 Cr |
How is Cash Flow from Financing Activities of SUPRIYA LIFESCIENCE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-22 Cr | Negative | |
Mar2023 | ₹-10 Cr | Negative | |
Mar2022 | ₹150 Cr | Positive | |
Mar2021 | ₹-15 Cr | Negative | |
Mar2020 | ₹-29 Cr | - |
Compare Cash Flow from Financing Activities of peers of SUPRIYA LIFESCIENCE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUPRIYA LIFESCIENCE | ₹5,408.4 Cr | -6.4% | -7.7% | 71.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,032.0 Cr | 0.9% | 2.2% | 23.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,252.0 Cr | 3.3% | 4.7% | 58% | Stock Analytics | |
CIPLA | ₹124,457.0 Cr | 0.5% | 2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,425.0 Cr | -0.4% | 2.8% | 24.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,152.8 Cr | -0.8% | -0.4% | 0.8% | Stock Analytics |
SUPRIYA LIFESCIENCE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUPRIYA LIFESCIENCE | -6.4% |
-7.7% |
71.3% |
SENSEX | 0.9% |
3% |
8.9% |
You may also like the below Video Courses